All stock lists
Unlock the score
Ecovyst Inc. (New York Stock Exchange:ECVT)
US · Delayed Price · Currency is USD
Basic Materials · Chemicals - Specialty
9.89+0.10 (+1.07%)
Market cap
$1.08B
Insider Score
Health Score
Analyst consensus
Listed since
Sep 29, 2017
Website
Insider Score
/ 100
ECVT Insider Score
Ecovyst Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
Financial Health Score
Sound
From ECVT’s reported statements · Q2 2026 (trailing 12 months)
Profitability6 / 20
Loses money on what it sells.
- Revenue
- $869.3M
- Net income
- -$61.3M
- Net margin
- -7.1%
Leverage6 / 20
Heavily indebted for what it earns.
- Total debt
- $546.4M
- Cash
- $87.8M
- Net debt / EBITDA
- 2.86x
Liquidity16 / 20
Comfortably covers what is due within a year.
- Current assets
- $261.3M
- Current liabilities
- $153.5M
- Current ratio
- 1.70
Cash generation16 / 20
The business funds itself from operations.
- Operating cash flow
- $148.3M
- Free cash flow
- $72.2M
- FCF margin
- 8.3%
Dilution & runway20 / 20
Not funding itself by issuing shares.
- Shares outstanding
- 109.5M
- Share growth (1y)
- -5.8%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
ECVT Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 250.00 M | 214.95 M | 199.43 M | 204.91 M | 200.13 M | 143.11 M |
| Revenue Growth (YoY) | 24.92 % | 50.20 % | 9.60 % | 14.36 % | 9.47 % | -10.86 % |
| Cost of Revenue | 200.20 M | 180.70 M | 152.68 M | 152.83 M | 153.06 M | 126.14 M |
| Gross Profit | 49.80 M | 34.26 M | 46.75 M | 52.08 M | 47.07 M | 16.97 M |
| SG&A Expense | 17.40 M | 19.13 M | 16.25 M | 15.66 M | 22.66 M | 16.50 M |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 30.40 M | 19.32 M | 21.22 M | 17.85 M | 25.32 M | 16.82 M |
| Operating Income | 19.40 M | 14.93 M | 25.53 M | 34.22 M | 21.75 M | 145.00 K |
| Pretax Income | 14.90 M | 9.34 M | 8.17 M | 20.57 M | 8.05 M | -10.37 M |
| Tax Provision | 4.20 M | 3.59 M | -476.00 K | 20.20 M | 2.06 M | -2.24 M |
| Net Income | 7.90 M | 4.31 M | 5.74 M | -79.25 M | 5.99 M | -3.60 M |
| EPS (Basic) | 0.07 | 0.04 | 0.05 | -0.70 | 0.05 | -0.03 |
| EPS (Diluted) | 0.07 | 0.04 | 0.05 | -0.70 | 0.05 | -0.03 |
| Shares Outstanding | 109.46 M | 110.69 M | 113.36 M | 113.90 M | 116.23 M | 117.26 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.